Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 8 | 2025 | 138 | 3.060 |
Why?
|
| Retrospective Studies | 16 | 2025 | 2485 | 1.740 |
Why?
|
| Wounds, Gunshot | 2 | 2025 | 30 | 1.720 |
Why?
|
| Maryland | 7 | 2025 | 61 | 1.350 |
Why?
|
| Health Services Accessibility | 3 | 2025 | 680 | 1.320 |
Why?
|
| Gastric Bypass | 3 | 2024 | 22 | 1.270 |
Why?
|
| United States | 14 | 2025 | 5072 | 1.180 |
Why?
|
| Depression | 2 | 2025 | 837 | 1.120 |
Why?
|
| Obesity, Morbid | 3 | 2024 | 29 | 1.100 |
Why?
|
| Thyroid Neoplasms | 2 | 2025 | 49 | 1.070 |
Why?
|
| Emergency Service, Hospital | 3 | 2025 | 268 | 1.010 |
Why?
|
| Coercion | 1 | 2025 | 11 | 0.930 |
Why?
|
| Female | 22 | 2025 | 24018 | 0.920 |
Why?
|
| Loneliness | 1 | 2025 | 22 | 0.920 |
Why?
|
| Postoperative Complications | 4 | 2024 | 253 | 0.890 |
Why?
|
| Adult | 17 | 2025 | 13458 | 0.880 |
Why?
|
| Body Image | 1 | 2025 | 87 | 0.870 |
Why?
|
| Community-Acquired Infections | 1 | 2024 | 22 | 0.870 |
Why?
|
| Graft Survival | 1 | 2024 | 47 | 0.840 |
Why?
|
| Wet Macular Degeneration | 1 | 2023 | 3 | 0.840 |
Why?
|
| Pneumonia | 1 | 2024 | 60 | 0.830 |
Why?
|
| Homicide | 1 | 2023 | 17 | 0.830 |
Why?
|
| Macular Degeneration | 1 | 2023 | 30 | 0.820 |
Why?
|
| Firearms | 1 | 2023 | 16 | 0.810 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 55 | 0.810 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 56 | 0.810 |
Why?
|
| Suicide, Attempted | 2 | 2024 | 104 | 0.800 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 102 | 0.790 |
Why?
|
| Humans | 28 | 2025 | 42163 | 0.770 |
Why?
|
| Middle Aged | 12 | 2025 | 11819 | 0.760 |
Why?
|
| Infertility | 1 | 2022 | 21 | 0.750 |
Why?
|
| Alcoholism | 2 | 2023 | 292 | 0.740 |
Why?
|
| Male | 17 | 2025 | 22779 | 0.730 |
Why?
|
| Suicide | 1 | 2023 | 139 | 0.730 |
Why?
|
| Mental Health | 1 | 2025 | 363 | 0.700 |
Why?
|
| Young Adult | 8 | 2025 | 4936 | 0.700 |
Why?
|
| Adolescent | 8 | 2025 | 5950 | 0.680 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2025 | 350 | 0.680 |
Why?
|
| Hospitalization | 1 | 2024 | 482 | 0.660 |
Why?
|
| Obesity | 3 | 2025 | 1131 | 0.650 |
Why?
|
| Students | 1 | 2025 | 617 | 0.620 |
Why?
|
| Neoplasm Staging | 3 | 2025 | 366 | 0.480 |
Why?
|
| Length of Stay | 2 | 2024 | 231 | 0.390 |
Why?
|
| Social Class | 3 | 2024 | 286 | 0.380 |
Why?
|
| SEER Program | 4 | 2025 | 157 | 0.370 |
Why?
|
| Socioeconomic Factors | 3 | 2024 | 1221 | 0.350 |
Why?
|
| Neoplasms | 1 | 2022 | 1341 | 0.350 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 573 | 0.320 |
Why?
|
| Aged | 4 | 2025 | 7982 | 0.300 |
Why?
|
| California | 2 | 2025 | 531 | 0.260 |
Why?
|
| Texas | 2 | 2025 | 428 | 0.250 |
Why?
|
| Hospital Mortality | 2 | 2024 | 206 | 0.240 |
Why?
|
| Nigeria | 1 | 2025 | 92 | 0.230 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2025 | 77 | 0.230 |
Why?
|
| Colectomy | 1 | 2024 | 21 | 0.220 |
Why?
|
| Vascular Surgical Procedures | 1 | 2024 | 15 | 0.220 |
Why?
|
| Residence Characteristics | 2 | 2024 | 359 | 0.220 |
Why?
|
| Retina | 2 | 2023 | 288 | 0.210 |
Why?
|
| Bariatric Surgery | 1 | 2023 | 20 | 0.210 |
Why?
|
| Carcinoma, Medullary | 1 | 2023 | 3 | 0.210 |
Why?
|
| Cesarean Section | 1 | 2024 | 63 | 0.210 |
Why?
|
| Incidence | 2 | 2024 | 1054 | 0.210 |
Why?
|
| Cicatrix | 1 | 2023 | 17 | 0.210 |
Why?
|
| Medically Uninsured | 1 | 2023 | 64 | 0.210 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 42 | 0.200 |
Why?
|
| Mediastinal Emphysema | 1 | 2023 | 1 | 0.200 |
Why?
|
| Insurance Coverage | 1 | 2024 | 108 | 0.200 |
Why?
|
| Pneumothorax | 1 | 2023 | 9 | 0.200 |
Why?
|
| Pregnancy Outcome | 1 | 2024 | 92 | 0.200 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2023 | 62 | 0.200 |
Why?
|
| Insurance, Health | 1 | 2024 | 143 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2023 | 48 | 0.200 |
Why?
|
| Visual Acuity | 1 | 2023 | 117 | 0.200 |
Why?
|
| Inpatients | 1 | 2023 | 78 | 0.200 |
Why?
|
| Treatment Outcome | 2 | 2024 | 1586 | 0.190 |
Why?
|
| Cause of Death | 1 | 2023 | 183 | 0.190 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 77 | 0.190 |
Why?
|
| Patient Readmission | 1 | 2024 | 120 | 0.190 |
Why?
|
| Logistic Models | 1 | 2025 | 1001 | 0.190 |
Why?
|
| Developed Countries | 1 | 2022 | 15 | 0.190 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 45 | 0.190 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 32 | 0.190 |
Why?
|
| Population Surveillance | 1 | 2023 | 245 | 0.190 |
Why?
|
| Health Status | 1 | 2025 | 432 | 0.180 |
Why?
|
| Registries | 1 | 2024 | 431 | 0.180 |
Why?
|
| Universities | 1 | 2025 | 539 | 0.180 |
Why?
|
| Violence | 1 | 2022 | 133 | 0.170 |
Why?
|
| Infant, Newborn | 1 | 2024 | 960 | 0.170 |
Why?
|
| Internship and Residency | 1 | 2022 | 141 | 0.170 |
Why?
|
| Poverty | 1 | 2023 | 395 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 479 | 0.160 |
Why?
|
| Pregnancy | 1 | 2024 | 1737 | 0.140 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 2803 | 0.140 |
Why?
|
| Quality of Life | 1 | 2022 | 599 | 0.130 |
Why?
|
| Prevalence | 1 | 2022 | 1597 | 0.130 |
Why?
|
| Risk Factors | 2 | 2023 | 3942 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3077 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 825 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1679 | 0.090 |
Why?
|
| Disease Progression | 2 | 2022 | 661 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2024 | 59 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2023 | 4 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 22 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2023 | 55 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 61 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 512 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 301 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 209 | 0.040 |
Why?
|
| Prognosis | 1 | 2023 | 850 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 358 | 0.040 |
Why?
|